Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $6.6300 (-4.19%) ($6.6300 - $6.9000) on Mon. Apr. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 24 | Latest Price | $6.6300(-4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(66%) IBB(53%) IWC(51%) IWO(46%) IWM(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.065% in a week (0% probabilities). SMH(-14%) IGOV(-14%) VXX(-12%) VIXM(-11%) BNDX(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.28(-224.89%) | Resistance Level | $7.52 | 5 Day Moving Average | $6.88(-3.63%) | 10 Day Moving Average | $7.05(-5.96%) | 20 Day Moving Average | $7.52(-11.84%) | To recent high | -41.9% | To recent low | 0% | Market Cap | $412m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |